Nutrition 21 Announces The Presentation Of A Preclinical Evaluation Of The Effect Of Nitrosigine® On Inflammatory Markers And Arthritis At The Renowned Experimental Biology 2017 Annual Meeting

Nitrosigine® Supplementation Effective in Reducing Inflammation Associated with Joint Health
Purchase, NY – April 20, 2017 – PURCHASE, NEW YORK – APRIL 25, 2017 – Nutrition 21, LLC (“Nutrition 21”) is proud to announce the presentation of new preclinical study results supporting Nitrosigine® bonded arginine silicate (ASI), titled, “Effect of Bonded Arginine Silicate on Inflammatory Markers and Arthritis.”